-
There are 4 common problems with infertility
Time of Update: 2023-01-04
Next, infertility-related examinations are performed, including: basal body temperature measurement, ultrasound follicle monitoring, sex hormone test, serum insulin test, thyroid function test, fallopian tube examination, immune factor related examination, hysteroscopy, laparoscopy, etc.
-
Immunity "Hit the snake seven inches" - an epitope target that EBV is easily neutralized and inhibited by fusion
Time of Update: 2023-01-01
MG collaborated to publish an article in the journal Immunity Epstein-Barr virus gH/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition Using a variety of serology, biochemistry, structural biology methods and humanized mouse challenge models, the epitope structure information on EBV gH/gL that is easily neutralized and inhibited by fusion was systematically revealed, which laid a theoretical foundation for understanding EBV invasion and infection of cells and developing preventive or therapeutic vaccines.
-
Gastric Cancer: A deep learning model predicts the efficacy of neoadjuvant chemotherapy for advanced gastric cancer
Time of Update: 2022-09-30
On this basis, the team proposes a new method for predicting efficacy based on the intelligent calculation technology of medical imaging based on the identification problem of neoadjuvant chemotherapy resistance patients in advanced gastric cancer.
-
EBioMedicine: Hepatitis B infection has a causal relationship with extrahepatic tumors: a Mendelian randomization study
Time of Update: 2022-09-30
The causal relationship between chronic HBV infection and extrahepatic tumors in individuals of Japanese East Asian ancestry was studied using the reverse variance weighting (IVW) method.
The causal relationship between chronic HBV infection and extrahepatic tumors in individuals of Japanese East Asian ancestry was studied using the reverse variance weighting (IVW) method.
-
Born for cell therapy, Yida Bio GMP-grade flow electrotransfection system conference
Time of Update: 2022-08-30
Born for Cell TherapyIn recent years, cell therapy has become a hot field of global attention . With the continuous approval of new cell therapy drugs, more patients have benefited from them, and eve
-
Preventing thyroid cancer and losing weight are "top priorities
Time of Update: 2022-06-06
Maarit Laaksonen from the School of Mathematics and Statistics, University of New South Wales, Australia, to assess the future burden of thyroid cancer found that overweight/obesity is an important cause of thyroid cancer.
-
Express $25 million to help develop a new generation of synthetic lethal therapy, Pfizer reaches R&D cooperation
Time of Update: 2022-05-31
Pfizer and Zentalis have entered into an agreement to collaborate to advance the clinical development of selective Wee1 inhibitors, an innovative therapy that uses the principle of synthetic lethality to kill cancer cells .
-
Save common cancer chemotherapy regimen abbreviation comparison table
Time of Update: 2022-05-21
In clinical work, do you often confuse the abbreviations of chemotherapy regimens?In clinical work, do you often confuse the abbreviations of chemotherapy regimens?
One, lung cancer one, lung cancer lung cancer two, breast cancer two, breast cancer breast cancer three, colorectal cancer 3.
colorectal cancercolorectal cancer 4.
Gastric cancer IV.
-
"Dual-target combination" new indication approved in my country, "dabrafenib" combined with "trametinib" brings a new option for patients with BRAF V600 mutant non-small cell lung cancer
Time of Update: 2022-04-23
This is not only the third approved indication of Tefero® and Megenin® , but also the first dual-targeted combination therapy drug approved in China for BRAF V600 mutation-positive metastatic non-small cell lung cancer .
-
BREAST CANCER RES TR: Asian data released
Time of Update: 2021-10-10
Myocardial infarctionIn summary, the results of the subgroup analysis of the study showed that the efficacy characteristics of Asian patients with HER2-positive advanced breast cancer who had failed two or more HER2-targeted therapies were consistent with the efficacy characteristics of the entire study population, neratinib + capecita Bin can benefit them significantly, and no new safety issues have been seen .
-
JCEM: The effect of TSH inhibitory therapy on bone mineral density in patients with differentiated thyroid cancer
Time of Update: 2021-07-27
As subclinical hyperthyroidism can increase the risk of osteoporosis and fractures, people are increasingly worried about the long-term safety of thyroid-stimulating hormone (TSH) suppression therapy for bones in patients with differentiated thyroid cancer (DTC) after total thyroidectomy.
-
The arrow of the times: the Chinese power behind the mRNA vaccine
Time of Update: 2021-06-17
According to public information, many Chinese companies have already developed mRNA COVID-19 vaccine research projects .
1. Aibo Biological Founded in Suzhou Industrial Park at the beginning of 2019, Aibo Biology is one of the earliest companies engaged in mRNA drug research and development in China.
-
JCO: Can recurrent ovarian cancer benefit from carboplatin intraperitoneal hyperthermic perfusion chemotherapy during secondary cytoreductive surgery
Time of Update: 2021-05-31
Ovarian cancerThis study aimed to evaluate the efficacy of carboplatin hyperthermic intraperitoneal perfusion chemotherapy (HIPEC) in patients with recurrent ovarian cancer during secondary cytoreductive surgery .
This study aims to evaluate the efficacy of carboplatin intraperitoneal hyperthermic perfusion chemotherapy (HIPEC) in patients with recurrent ovarian cancer during secondary cytoreductive surgery.
-
Br J Cancer: ALG5: Biomarker candidate for malignant slurry ovarian cancer
Time of Update: 2021-02-01
136 late HGSOC cases with CGR were identified from three common transcription set data sets in patients with advanced HGSOC tumors and improved prognostication.
-
The draft period is extended: Genome Biology The evolution and metastasis of cancer
Time of Update: 2020-12-30
multi-group big data research makes us gradually change the view of tumor occurrence and development, modern tumor evolution concept often from the perspective of dynamic groupization to understand the occurrence and development of tumor.
